Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Gene expression atlas of a developing tissue by single cell expression correlation analysis.

Bageritz J, Willnow P, Valentini E, Leible S, Boutros M, Teleman AA.

Nat Methods. 2019 Aug;16(8):750-756. doi: 10.1038/s41592-019-0492-x. Epub 2019 Jul 29.

PMID:
31363221
2.

Single-Cell RNA Sequencing with Drop-Seq.

Bageritz J, Raddi G.

Methods Mol Biol. 2019;1979:73-85. doi: 10.1007/978-1-4939-9240-9_6.

PMID:
31028633
3.

Retinoid resistance and multifaceted impairment of retinoic acid synthesis in glioblastoma.

Campos B, Weisang S, Osswald F, Ali R, Sedlmeier G, Bageritz J, Mallm JP, Hartmann C, von Deimling A, Popanda O, Goidts V, Plass C, Unterberg A, Schmezer P, Burhenne J, Herold-Mende C.

Glia. 2015 Oct;63(10):1850-9. doi: 10.1002/glia.22849. Epub 2015 May 6.

PMID:
25944104
4.

Functional characterization of ENPP1 reveals a link between cell cycle progression and stem-like phenotype in glioblastoma.

Bageritz J, Goidts V.

Mol Cell Oncol. 2014 Dec 23;1(3):e964028. doi: 10.4161/23723548.2014.964028. eCollection 2014 Jul-Sep.

5.

Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma.

Campos B, Gal Z, Baader A, Schneider T, Sliwinski C, Gassel K, Bageritz J, Grabe N, von Deimling A, Beckhove P, Mogler C, Goidts V, Unterberg A, Eckstein V, Herold-Mende C.

J Pathol. 2014 Sep;234(1):23-33. doi: 10.1002/path.4366. Epub 2014 Jul 10.

PMID:
24756862
6.

Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1.

Bageritz J, Puccio L, Piro RM, Hovestadt V, Phillips E, Pankert T, Lohr J, Herold-Mende C, Lichter P, Goidts V.

Cell Death Differ. 2014 Jun;21(6):929-40. doi: 10.1038/cdd.2014.12. Epub 2014 Feb 14.

7.

LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells.

Nakata S, Campos B, Bageritz J, Bermejo JL, Becker N, Engel F, Acker T, Momma S, Herold-Mende C, Lichter P, Radlwimmer B, Goidts V.

Brain Pathol. 2013 Jan;23(1):60-72. doi: 10.1111/j.1750-3639.2012.00618.x. Epub 2012 Aug 30.

PMID:
22805276
8.

Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro.

Dittmann LM, Danner A, Gronych J, Wolter M, Stühler K, Grzendowski M, Becker N, Bageritz J, Goidts V, Toedt G, Felsberg J, Sabel MC, Barbus S, Reifenberger G, Lichter P, Tews B.

Oncogene. 2012 Jul 19;31(29):3409-18. doi: 10.1038/onc.2011.513. Epub 2011 Dec 12.

PMID:
22158042
9.

RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival.

Goidts V, Bageritz J, Puccio L, Nakata S, Zapatka M, Barbus S, Toedt G, Campos B, Korshunov A, Momma S, Van Schaftingen E, Reifenberger G, Herold-Mende C, Lichter P, Radlwimmer B.

Oncogene. 2012 Jul 5;31(27):3235-43. doi: 10.1038/onc.2011.490. Epub 2011 Nov 7.

PMID:
22056879
10.

An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice.

Gronych J, Korshunov A, Bageritz J, Milde T, Jugold M, Hambardzumyan D, Remke M, Hartmann C, Witt H, Jones DT, Witt O, Heiland S, Bendszus M, Holland EC, Pfister S, Lichter P.

J Clin Invest. 2011 Apr;121(4):1344-8. doi: 10.1172/JCI44656. Epub 2011 Mar 14.

Supplemental Content

Loading ...
Support Center